1 |
Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., and Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
DOI
ScienceOn
|
2 |
Zhang, D., Sun, M., Samols, D., and Kushner, I., STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin- 6. J. Biol. Chem. 271, 9503-9509 (1996).
DOI
|
3 |
Zhou, J., Wang, Q., Wang, Q., and Duan, W., Effects of norcantharidin on lipopolysaccharide-induced hepatocyte injury in vitro. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37, 285-289 (2012).
|
4 |
Zhou, J., Wang, Q., Wang, Q., and Duan, W., Effects of norcantharidin on lipopolysaccharide-induced hepatocyte injury in vitro. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37, 285-289 (2012).
|
5 |
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., and Van Obberghen, E., SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275, 15985-15991 (2000).
DOI
ScienceOn
|
6 |
Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P., and Bahouth, S.W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282 (2004).
DOI
ScienceOn
|
7 |
Guo, H.X., Liu, D.H., Ma, Y., Liu, J.F., Wang, Y., Du, Z.Y., Wang, X., Shen, J.K., and Peng, H.L., Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta. Pharmacol. Sin. 30, 1505-1512 (2009).
DOI
ScienceOn
|
8 |
Ganapathi, M.K., Rzewnicki, D., Samols, D., Jiang, S.L., and Kushner, I., Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J. Immunol. 147, 1261-1265 (1991).
|
9 |
Haas, J.T. and Biddinger, S.B., Dissecting the role of insulin resistance in the metabolic syndrome. Curr. Opin. Lipidol. 20, 206-210 (2009).
DOI
ScienceOn
|
10 |
Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegelman, B.M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF and obesity-induced insulin resistance. Science 271, 665-668 (1996).
DOI
ScienceOn
|
11 |
Klover, P.J., Clementi, A.H., and Mooney, R.A., Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146, 3417-3427 (2005).
DOI
ScienceOn
|
12 |
Klover, P.J., Zimmers, T.A., Koniaris, L.G., and Mooney, R.A., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789 (2003).
DOI
ScienceOn
|
13 |
Krakauer, T., Li, B.Q., and Young, H.A., The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS Lett. 500, 52-55 (2001).
DOI
ScienceOn
|
14 |
Kramer, F., Torzewski, J., Kamenz, J., Veit, K., Hombach, V., Dedio, J., and Ivashchenko, Y., Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaBand C/EBPbeta-dependent autocrine interleukin-6 loop. Mol. Immunol. 45, 2678-2689 (2008).
DOI
ScienceOn
|
15 |
Li, H.T., Wu, X.D., Davey, A.K., and Wang, J., Antihyperglycemic effects of baicalin on streptozotocin - nicotinamide induced diabetic rats. Phytother. Res. 25, 189-194 (2011).
|
16 |
Lixuan, Z., Jingcheng, D., Wenqin, Y., Jianhua, H., Baojun, L., and Xiaotao, F., Baicalin attenuates inflammation by inhibiting NFkappaB activation in cigarette smoke induced inflammatory models. Pulm. Pharmacol. Ther. 23, 411-419 (2010). Li, Y., Ding, L., Hassan, W., Abdelkader, D., and Shang, J., Adipokines and hepatic insulin resistance. J. Diabetes Res. 2013, 170532-170539 (2013).
|
17 |
Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnuson, M.A., and Kahn, C.R., Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell. 6, 87-97 (2000).
DOI
ScienceOn
|
18 |
Meshkani, R. and Adeli, K., Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 42, 1331-1346 (2009).
DOI
ScienceOn
|
19 |
Petersen, K.F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R.E., and Shulman, G.I., Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54, 603-608 (2005).
DOI
ScienceOn
|
20 |
Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M., Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J. Am. Med. Assoc. 286, 327-334 (2001).
DOI
ScienceOn
|
21 |
Ridker, P.M. and Morrow, D.A., C-reactive protein, inflammation, and coronary risk. Cardiol. Clin. 21, 315-325 (2003).
DOI
ScienceOn
|
22 |
Saad, B., Frei, K., Schol, F.A., Fontana, A., and Maier, P., Hepatocytederived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes. Eur. J. Biochem. 229, 349-355 (1995).
DOI
ScienceOn
|
23 |
Senn, J.J., Klover, P.J., Nowak, I.A., and Mooney, R.A., Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391- 3399 (2002).
DOI
ScienceOn
|
24 |
Senn, J.J., Klover, P.J., Nowak, I.A., Zimmers, T.A., Koniaris, L.G., Furlanetto, R.W., and Mooney, R.A., Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746 (2003).
DOI
ScienceOn
|
25 |
Tanti, J.F., Gremeaux, T., van Obberghen, E., and Le Marchand-Brustel, Y., Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269, 6051-6057 (1994).
|
26 |
Ueki, K., Kondo, T., and Kahn, C.R., Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 24, 5434-5446 (2004).
DOI
ScienceOn
|
27 |
Xi, L., Xiao, C., Bandsma, R.H., Naples, M., Adeli, K., and Lewis, G.F., C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen-activated protein kinases. Hepatology 53, 127-135 (2011).
DOI
ScienceOn
|